ADAL

ADAL

Target · Metabolic enzyme

ADAL N6-Methyl-AMP deaminase · adenosine deaminase like

ADAL, now named N6-methyl-AMP deaminase (gene symbol MAPDA), is a cytosolic deaminase of the adenosine deaminase family. It clears methylated adenosine nucleotides derived from RNA turnover, and was previously known as adenosine deaminase like. Browse Assay Genie's current range of ADAL research reagents below, or read on for the biology behind the target.

Cytosolic enzymeDetoxifies methylated adenosinesActs downstream of ADK
355 aa
Protein length
~40 kDa
Molecular weight
15q15.3
Gene locus
EC 3.5.4.-
Enzyme class
Target information

What is ADAL (N6-Methyl-AMP deaminase)?

ADAL is a deaminase involved in the detoxification of modified adenosines that carry the N(6)-methyladenine (m6A) post-transcriptional modification. Modified nucleosides arise from the degradation of RNAs, including mRNAs, rRNAs and tRNAs. They have intrinsic cytotoxicity and must be cleared to prevent metabolic dysfunction. ADAL acts downstream of ADK and catalyses the hydrolysis of free cytosolic methylated adenosine nucleotides, namely N(6)-methyl-AMP (m6AMP), N(6),N(6)-dimethyl-AMP (m6,6AMP) and N(6)-isopentenyl-AMP (i6AMP), to produce IMP.

In vitro, the enzyme removes different alkyl groups, not only from N6-substituted purine or 2-aminopurine nucleoside monophosphates but also from O6-substituted compounds. NCBI Gene describes it as enabling N6-methyl-AMP deaminase activity, involved in toxic metabolite repair and predicted to be active in the cytosol, which matches the cytosolic localisation recorded in UniProt.

The ADAL gene is also known by the HGNC symbol MAPDA, and the mouse ortholog is Mapda. The protein belongs to the metallo-dependent hydrolases superfamily and to the adenosine and AMP deaminases family, and HGNC places it in the adenosine deaminase family. Its earlier name, adenosine deaminase like, reflects this relationship, while the current name reflects its characterised substrate preference for N6-methylated AMP.

RNA modification metabolism

ADAL clears nucleotides derived from m6A-modified RNA, making it relevant to how cells handle the products of mRNA, rRNA and tRNA degradation.

Toxic metabolite repair

The enzyme detoxifies modified adenosines that are intrinsically cytotoxic, so it is studied as part of metabolite repair and the prevention of metabolic dysfunction.

Purine nucleotide metabolism

ADAL acts downstream of ADK and converts methylated AMP species to IMP, linking modified nucleoside salvage to the wider purine pathway.

Deaminase enzymology

Its in vitro removal of alkyl groups from N6- and O6-substituted purine nucleotides makes it a useful model for substrate specificity in the adenosine deaminase family.

Background

ADAL frequently asked questions

What does ADAL do?

ADAL is a cytosolic deaminase that detoxifies N(6)-methylated adenosine nucleotides released when RNA is degraded. Acting downstream of ADK, it hydrolyses m6AMP, m6,6AMP and i6AMP to produce IMP, preventing build-up of these cytotoxic modified nucleosides.

Why does ADAL have several names, including MAPDA?

ADAL is the long-standing alias, derived from the previous name adenosine deaminase like. The current HGNC name is N6-methyl-AMP deaminase, with the gene symbol MAPDA, reflecting its demonstrated activity on N6-methylated AMP. The names refer to the same gene and protein.

Is ADAL conserved across species?

The mouse has an ortholog named Mapda. Human ADAL belongs to the metallo-dependent hydrolases superfamily and the adenosine and AMP deaminases family. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other adenosine and AMP deaminases and purine-metabolism enzymes that act alongside ADAL.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q6DHV7; product specifications from Assay Genie datasheets.

ADAL Product listing